Biosimilars
A biosimilar is a biologic that is characterized as having the same amino acid sequence as an US FDA-approved product and nearly identical pharmacokinetic and biological activity. They are also known as a ‘follow-on biologic’ as they are subsequent versions of an innovator biologic product.
Sign up for our Bioanalysis Zone weekly news round-up